Emerging risks | Growth Opportunities | APAC Insurance

Thursday, November 19, 2026

Report: China Life invests US $42.4m in Series B round for Yingke Biopharmaceutic

Yingke was established in 2022 and is engaged in the R&D of pharmaceutical drugs
June 5, 2023

 • 

1 min read
(Re)in AsiaSIRC 2026 Hub(Re)in AsiaSIRC 2026HubExplore the hub →

Unlock this insight for free

Register for a free 14-day trial to read the full insight.

  • 14 days of access to (Re)in Asia’s premium intelligence
  • Free daily briefing in your inbox each morning
  • No credit card required
(Re)in AsiaSIRC 2026 Hub(Re)in AsiaSIRC 2026HubExplore the hub →